Authors
Latest:
Removing Mesna From Cyclophosphamide Cycles in VAdriaC-IE for Ewing SarcomaThis retrospective cohort study provides preliminary evidence for safe removal of mesna from VAdriaC cycles, as the incidence of hemorrhagic cystitis did not increase in patients with Ewing sarcoma who received cyclophosphamide without prophylactic mesna.
Latest:
ChatRx: Responsible AI Use for Clinical PharmacistsPharmacists, in particular, must be cautious and deliberate in using ChatGPT to ensure that its benefits are fully realized while minimizing risk and misinformation.
Latest:
The Power of Integrated Data Feeds to Support Drug Diversion DetectionA centralized, artificial intelligence–driven approach can integrate diverse data and foster multidisciplinary collaboration.
Latest:
Emerging BCMA-Directed Therapies in Multiple Myeloma: Bispecific Antibodies and CAR T-Cell TherapiesHere is an updated overview of the role of BCMA-directed therapies following the 2024 ASCO Annual Meeting and EHA Congress.
Latest:
Kevin’s Law Makes 72-Hour Supply of More Medication Available to PatientsEighteen states have enacted legislation that allows pharmacists to help patients when providers are not reachable.
Latest:
US Supreme Court Undercuts Long-Standing Judicial Deference to Administrative AgenciesRuling potentially affects federal ability to regulate pharmacy.
Latest:
Direct Oral Anticoagulant Use for Left Ventricular Thrombus TreatmentAn overview of the use of direct oral anticoagulants as an alternative to warfarin in the treatment of left ventricular thrombus.
Latest:
Novel Immunotherapy in Up-front Setting Shows Improved Outcomes in ALLStudy data demonstrate large step forward for this patient population
Latest:
Clinical Overview: Turmeric for the Management of OsteoarthritisPatients often turn to dietary supplements for the management of osteoarthritis, one of which is turmeric.
Latest:
Expanding the Role of the Pharmacist in the Wake of COVID-19Community pharmacists should consider leaning on their specialty pharmacist peers, where available, as we continue to navigate the new, more virtual normal and attempt to expand these types of services in the future.
Latest:
Cultural Competence Sets Pharmacy Professionals ApartTraining and knowledge about appropriate communication with individuals of diverse backgrounds improves adherence, outcomes.
Latest:
SGLT2 Inhibitors Are Underutilized for Inpatient Heart Failure TreatmentCardioprotective antihyperglycemic agents are underutilized for inpatient care in heart failure patients. Lack of use can lead to preventable patient deaths and hospital readmissions.
Latest:
Good Samaritan Laws Aim to Encourage AssistanceBut in real-world situations, such as when a bystander administers naloxone, there are gray areas.
Latest:
Baby Steps to a Healthier You: Prioritizing Lifestyle Changes Over MedicationTake these 4 steps to help prevent health conditions and disease naturally.
Latest:
Updates on 2022 Changes to the American Diabetes Association Standards of CareMetformin has been the drug of choice for the treatment of diabetes since the 1950s, but new changes suggest the consideration of SGLT-2 inhibitors or GLT-1 agonists.
Latest:
Changing the Game: Pharmacy Students' Perspective on Naloxone OTC ApprovalTo eliminate the existing stigma in the community, addiction must be recognized as a treatable condition rather than an immoral act.
Latest:
Lung Cancer Study Brings Pharmacists to the Forefront of Patient CarePharmacists have always been a vital member of the cancer care team, but the emergence of many new oral therapies is making their role in patient care a more prominent one.
Latest:
HER2 and HER3 in NSCLC: The Latest ADC Data and NCCN Guideline UpdatesCorrine Stahura, PharmD, and Sophia Gilardone, PharmD, BCOP, discuss recent clinical trial data and evolving guideline recommendations for HER2- and HER3-directed antibody-drug conjugates (ADCs) in non–small cell lung cancer (NSCLC), highlighting differences in efficacy, safety, and patient selection criteria.
Latest:
How Specialty Pharmacies Can Increase Access Through Patient FinancingIt’s essential that health care providers across the patient journey demystify the costs of treatment and provide solutions to overcome the financial barriers.
Latest:
A Review of Oral Cephalosporins for Common Outpatient InfectionsCephalosporins are commonly prescribed in the outpatient setting; understanding differences among them is important for pharmacists.
Latest:
Clinical Overview: Comparison of Anti-Amyloid Monoclonal Antibodies for Alzheimer DiseaseAducanumab, lecanemab, and donanemab are novel monoclonal antibodies designed to slow disease progression and hopefully have a positive impact in the field of Alzheimer disease management.
Latest:
Looking Toward the Future of CDI ManagementClosing out their discussion on Clostridioides difficile infection, panelists share closing thoughts on novel pipeline therapies.
Latest:
ASCO 2025: Stratifying NSCLC Treatment by HER2-Alteration SubtypeNikita Dahake, MD; Hossein Borghaei, DO, MS; and Yasmine Baca, MS, PhD candidate, MB(ASCP)CM, explore how distinct HER2-alteration subtypes in non-small cell lung cancer (NSCLC) impact survival outcomes, co-mutation profiles, and treatment response to immunotherapy-based regimens.
Latest:
Efficiency, Education, and Evolution: What’s Next for Pharmacy Practice?Scott Soefje, PharmD, MBA, BCOP, shares insights about the evolving role of pharmacists at the 2025 OPC meeting.
Latest:
Pharmacy Technicians as Non-Pharmacist Preceptors for a Sterile Compounding RotationRecognizing pharmacy technicians as non-pharmacist preceptors can provide an opportunity for professional development while encouraging technicians to practice at the top of their education and training activities.
Latest:
GOLD Guidelines Provide Recommendations on Managing COPDPivotal resource helps health care professionals diagnose, manage, and prevent this group of lung diseases.
Latest:
Clinical Overview: Treatment Recommendations for Pneumococcal DiseaseTreatment for community-acquired pneumococcal disease is dependent on patient-specific factors, whereas prevention with vaccinations is dependent on age and comorbidities.
